Signatur Biosciences (Future Equity)

Funding Details
Awarder
WeFunder
Date Award
June 13, 2024
Vertical
Healthcare
Funding URL
View Funding Page
Valuation
$15,000,000

Company Info
Traction
In just two months, Signatur Biosciences has clinically proven their technology, secured 6+ LOIs, and established partnerships with key industry players. They have raised $935k in the current round from investors including Amar Shah, a unicorn founder.
Organizations Involved
Y Combinator, Paradise Genomics, Biomedica, Imperial College London, Biotechne, AstraZeneca, Roche, Biocartis, Visby Medical, Sherlock Biosciences
Founders
Celestin de Wergifosse, John Goertz
Company Description
Signatur Biosciences is a biotech company that offers bringing molecular diagnostics services for cancer patients.
Market
Biotech
Location
San Francisco, CA, US
Coinvestors
Amar Shah (Wayve)

Links
Back to Home Back to Healthcare Deals View Funding Announcement